In light of the data showing that modulation of impaired mTORC1 signaling can result in destabilized mTOR complexes, modulation of GβL/mLST8 might lead to impaired mTOR signaling, making cancer cells more susceptible to mTOR-targeted therapies by promoting cell death pathways such as apoptosis or autophagy. Here, MLST8 is linked to cancer.